LuSeed Vascular

I’ll be presenting at LSI Europe ‘24 this September. Looking forward to connecting and discussing opportunities for growth and collaboration. #LSIEurope24 #Medtech #Healthtech #LSI #Stroke

Honored to be part of this insightful expert group advocating for crucial changes in EU regulations on medical device development. ? A collective of leading experts, convened recently to urge the European Union to reform its regulatory framework. The current rules, while well-intentioned, are hindering innovation and delaying patient access to life-saving treatments, particularly in areas like stroke care. ? The effects of current EU regulations reach far beyond just the EU population. They're not just holding back access to new tech for EU but also causing delays for many countries that depend on EU standards. This ripple effect touches medical development worldwide and across different fields. Let's hope for some positive changes so that everyone who needs life saving medical tech can get it when they need it. https://lnkd.in/dSYkkgfE

SHAAR leads healthcare innovation in the Holy City! This week, we united SHAAR’s global partners with MedTech startups for interactive sessions in the #Jerusalem ecosystem at our #SHAARMedTech Program.??? ??? The program fostered a dynamic convergence of healthcare and technology with over 430 impactful one-on-one meetings that connected medical leaders and investors with the ten promising startups.? ??? Closing with an exciting Final Expo and Pitch Event at Shaare Zedek Medical Center, we gathered industry leaders and investors to meet the incredible selected startups: ? ? BeCapio: Novel multi-layer therapy to help patients dealing with accidental bowel leakage (FI) CaleeTech: Smart polymer-based transient GI barrier to effectively reduce absorption of glucose, cholesterol & other obesogens GentaGel-LR: Injectable, biodegradable local sustained release of antibiotics for prevention & treatment of infections LuSeed Vascular: LuSeed Vascular provides a simpler, comprehensive solution for treating brain aneurysms, by introducing the first device capable of treating both aneurysm subtypes safely and effectively? Panacea-ml: Panacea-ml predicts clinical trial outcomes through explainable machine learning (AI) to enable better decision making and to reduce clinical development risk Predicta Med: An AI based Clinical Decision Support Platform for early detection and treatment recommendation of autoimmune diseases. Sherman Diagnostics: We enable rapid and gold standard accurate, any multiple pathogens detection from any sample for point of care /need using novel bio-convergence technology, a platform system and microfluidic disposable cassette, to speed up intervention. Snipe Medical: Developing a solution for Lung Cancer using Minimal Invasive Novel IRE Ablation SORLIS: SORLIS enhances healthcare by providing a non-invasive system for early detection and prevention of pressure ulcers, utilizing smart sensors and AI? TechnoPulm: Shifting Point Of Care for Respiratory Disease Diagnostics and Monitoring from Hospitals to the community? ? We were highly impressed with the ventures’ forward-thinking approaches to personalized medicine, telemedicine, remote patient monitoring, medical devices, and artificial intelligence.? ??? It was a privilege to establish this program in collaboration with our partners and supporters and we extend love and thanks to our partners, guests, industry leaders, investors and startups. Looking ahead, we're excited about the upcoming stages of our program and the innovative events planned at the SHAAR hub. We remain committed to fostering groundbreaking collaborations in MedTech, and eagerly anticipate the continued growth that our partnerships will bring.? ??? Arieli Capital Shaare Zedek Scientific (Madait) Shaare Zedek Medical Center, Jerusalem The Jerusalem Development Authority (JDA)? Social Space Bezalel Academy of Art and Design ROOMS by Fattal? Amit, Pollak, Matalon & Co.

I'm excited to share my recent experience at the J.P. Morgan Healthcare Conference. Representing LuSeed as a part of the Israeli delegation was a remarkable honor. During the conference, we presented the latest safety and efficacy data from LuSeed's ongoing clinical trials. Discussions with potential stakeholders and collaborators about the future directions of LuSeed were deeply engaging. Our groundbreaking 'one and done' approach for treating both Sidewall and Bifurcating aneurysms places LuSeed at the cutting edge of medical innovation. The enthusiastic feedback and interest we garnered underscore the significant potential of our work. I am particularly thankful to Naftali Bennett, the former Israeli Prime Minister, for sharing his invaluable insights. His unique perspective as both a distinguished entrepreneur and a national leader. I would also like to extend a heartfelt thanks to the Israel Economic Mission to the West Coast – specifically to Omer Fein, Sarah Benjamin, and Karin Mor – for their outstanding support. And David Kaufman's contribution to the CICC and the Technion institute #JPM2024 #HealthcareInnovation #MedicalDevices #LuSeed #TransformingLives